Trials / Terminated
TerminatedNCT01986127
Adalimumab Intralesional in Intestinal Strictures of Crohn's Disease Patients
A Randomized, Double-blinded, Placebo-controlled Study on the Effects of Adalimumab Intralesional Intestinal Strictures of Crohn's Disease Patients
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Sara Varea · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We study if the administration of intralesional Adalimumab (directly injected in the stricture) associated to endoscopic dilatation has a higher success rate at week 8 compared with placebo in patients with Crohn's disease who had confirmed intestinal stenosis (3 stenosis as maximum)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adalimumab | single intralesional administration during endoscopy process |
| DRUG | placebo | single intralesional administration during endoscopy |
Timeline
- Start date
- 2014-02-14
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
- First posted
- 2013-11-18
- Last updated
- 2018-12-13
Locations
13 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT01986127. Inclusion in this directory is not an endorsement.